Sotera Health Co (SHC) research
Sotera Health Co- Sector
- Life Sciences Tools & Services
- Last price
- $18.22
- As of
Sotera Health Co (SHC): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-14.
As of . Source: SEC EDGAR filings for SHC. Method and limitations.
Share the SHC intelligence card
See the full SHC dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SHC on one page. Preview it with sample data, then open it live with a free account.
Preview the SHC dossierActive signals for SHC
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +506% to SHC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +10566% to SHC (2026Q2)
- highINSTITUTIONAL_EXIT
Bridgewater Associates, LP cut 97% of SHC (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 7.6%, EPS $0.26 vs $0.2416 estimate
- highCONSENSUS_SELL
3 tracked funds reduced SHC this 2026Q1 - institutional consensus
FREE, NO ACCOUNT
Every signal on SHC, as it fires
You are seeing 5 of 13 signals recorded on SHC since 2026-05-24.
The five above landed across 3 days. The other 8 were recorded on 1 other days. 8 of the 13 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SHC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 83601L102 · 2026Q2 | $35.6M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 83601L102 · 2026Q2 | $34.3M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 83601L102 · 2026Q2 | $2.7M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 83601L102 · 2026Q2 | $342K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SHC
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SHC against its peers
SHC's net margin of 6.7% ranks in the 67th percentile of 25 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | SHC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.2B USD | 1.2B USD | 48 | 25 |
| Gross margin | 55.5% | 59.2% | 42 | 12 |
| Operating margin | n/a | -6.6% | n/a | 24 |
| Net margin | 6.7% | -6.8% | 67 | 25 |
| Return on equity | 12.9% | -7.5% | 78 | 24 |
| P / E | 67.5x | 41.0x | 77 | 10 |
Peers (25): ADPT, ABCL, BRKR, AVTR, RGEN, TECH, TXG, CRL, FTRE, TEM, MEDP, MRVI, MTD, DNA, PACB, CTKB, MLAB, OABI, ILMN, WAT, IQV, A, DHR, CDXS, MXCT. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SHC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more SHC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SHCand get the insider, 13F, options, and confluence read in one view.